Combination of all-trans-retinoic acid and gemtuzumab ozogamicin in an elderly patient with acute promyelocytic leukemia and severe cardiac failure

Acta Haematologica

Volumn 117, Issue 3, 2007, Pages 188-190

  Finizio, O ^a   Pezzullo, L ^a   Rocco, S ^a   Bene, L ^a   De Rosa, C ^a   Nunziata, G R ^a   Mettivier, V ^a  

^a CARDARELLI HOSPITAL   (Italy)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Cardiac failure, severe; Gemtuzumab ozogamicin

Indexed keywords

GEMTUZUMAB OZOGAMICIN; RETINOIC ACID; WARFARIN;

AGED; ANAMNESIS; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; DISEASE SEVERITY; DRUG FEVER; ELECTROCARDIOGRAM; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; LEUKEMIA REMISSION; MAINTENANCE THERAPY; MALE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THROMBOCYTOPENIA;

AGED; AMINOGLYCOSIDES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TRETINOIN;

EID: 33947692243     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097880     Document Type: Article

References (10)

1. Fenaux P, Chastang C, Chevret S, Sanz MA, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Cony Makhoul P, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L, European APL Group: A randomized comparison of all-trans-retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-1200.
2. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Vehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F: Molecular remission in PML-RARα-positive acute promyelocytic leukemia by combined all- trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997;90:1014-1021.
3. Sanz MA, Martin G, Rayon C, Esteve J, Gonzalez M, Diaz-Mediavilla JM, Bolufer P, Barragan E, Terol MJ, Gonzalez J, Colomer D, Chillon C, Rivas C, Gomez T, Ribera JM, Bornstein R, Roman J, Calasanz M, Arias J, Alvarez C, Ramos F, Deben G, PETHEMA Group: A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia. Blood 1999;94:3015-3021.
4. Tallman M, Andersen J, Schiffer C , Appelbaum F, Feusner J, Ogden A, Shepherd L, Willman C, Bloomfield C, Rowe J, Wiernik P: All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337:1021-1028.
5. Ades L, Chevret S, De Botton S, Thomas X, Dombret H, Beve B, Sanz MA, Guerci A, Miguel JS, dela Serna J, Garo C, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn YH, Sotto JJ, Bourhis JH, Parry H, Chomienne C, Degos L, Fenaux P, European APL Group: Outcome of acute promyelocytic leukaemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience. Leukemia 2005;19:230-233.
6. Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F, Gobbi M, Nobile F, Gallo E, Fanin R, Amadori S, Vignetti M, Fioritoni G, Ferrara F, Peta A, Giustolisi R, Broccia G, Petti MC, Lo-Coco F, Italian GIMEMA Cooperative Group: Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia: results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols. Leukemia 2003;17:1085-1090.
7. Sanz MA, Vellenga E, Rayon C, Diaz-Mediavilla J, Rivas C, Amutio E, Arias J, Deben G, Novo A, Bergua J, de la Serna J, Bueno J, Negri S, Beltran de Heredia JM, Martin G: All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood 2004;104:3490-3994.
8. Estey EH, Giles FJ, Beran M, O'Brien S, Pierce SA, Faderl SH, Cortes JE, Kantarjian HM: Experience with gemtuzumab ozogamicin ('mylotarg') and all-trans retinoic acid in untreated acute promyelocytic leukemia. Blood 2002;99:4222-4224.
9. Estey E, Garcia-Manero G, Ferrajoli A, Faderl S, Verstovsek S, Jones D, Kantarjian H: Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood 2006;107:3469-3473.
10. Sanz MA, Lo-Coco F, Martin G, Avvisati G, Rayon C, Barbui T, Diaz-Mediavilla J, Fioritoni G, Gonzalez JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F: Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000;96:1247-1253.